Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bayer Reiterates Pharma Commitment Post-Monsanto, Plays Up Pipeline

Sep 20 2016

• By Joseph Haas

Merging Business Network-Business leaders in global agreement

Related Content

Dekkers: New Bayer Is Stable And Fit To Innovate for All Species

Oct 29 2015

Is Bayer Making A Mistake With Monsanto When Pharma Is Its Leading Business?

Jul 27 2016

Changes Brewing At Bayer, But Pharma Strategy Remains On Point

Jul 21 2016

Related Companies

Bayer AG

Merck & Co., Inc.

ERS Genomics Limited

Progenics Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

CRISPR Therapeutics AG

Sprint Bioscience AB

Acura Pharmaceuticals, Inc.

Johns Hopkins University

Wilmer Eye Institute

Astellas Pharma, Inc.

University of Oxford

Dimension Therapeutics

Orion

argenx N.V.

Johnson & Johnson

Additional Topics

Germany Europe Business Strategies M & A Deals Commercial Sales & Earnings Cancer Cardiovascular

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window